Entry
Name
Hepatitis C - Cricetulus griseus (Chinese hamster)
Description
Hepatitis C virus (HCV) is a major cause of chronic liver disease. The HCV employ several strategies to perturb host cell immunity. After invasion, HCV RNA genome functions directly as an mRNA in the cytoplasm of the host cell and forms membrane-associated replication complexes along with non-structural proteins. Viral RNA can trigger the RIG-I pathway and interferon production during this process. Translated HCV protein products regulate immune response to inhibit the action of interferon. HCV core and NS5A proteins appear to be the most important molecules with regulatory functions that modulate transcription, cellular proliferation, and apoptosis.
Class
Human Diseases; Infectious disease: viral
BRITE hierarchy
Pathway map
Ortholog table
Organism
Cricetulus griseus (Chinese hamster) [GN:
cge ]
Gene
100764931 Mavs; mitochondrial antiviral-signaling protein isoform X1 [KO:K12648 ]
100770607 Nfkb1; nuclear factor NF-kappa-B p105 subunit isoform X3 [KO:K02580 ]
107977044 interferon-induced protein with tetratricopeptide repeats 1-like isoform X2 [KO:K14217 ]
100772509 interferon-induced protein with tetratricopeptide repeats 1 isoform X1 [KO:K14217 ]
100774174 interferon-induced protein with tetratricopeptide repeats 1-like isoform X2 [KO:K14217 ]
100767358 LOW QUALITY PROTEIN: interferon-induced protein with tetratricopeptide repeats 1-like [KO:K14217 ]
100771190 Eif3e; eukaryotic translation initiation factor 3 subunit E isoform X2 [KO:K03250 ]
100761915 Eif2s1; eukaryotic translation initiation factor 2 subunit 1 [KO:K03237 ]
100755865 Stat3; signal transducer and activator of transcription 3 isoform X9 [KO:K04692 ]
100755609 Stat1; signal transducer and activator of transcription 1-alpha/beta isoform X1 [KO:K11220 ]
100764772 Stat2; signal transducer and activator of transcription 2 isoform X1 [KO:K11221 ]
100764653 interferon-induced GTP-binding protein Mx1-like isoform X2 [KO:K14754 ]
100753921 Rsad2; radical S-adenosyl methionine domain-containing protein 2 [KO:K15045 ]
100771272 Ppp2r1b; serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform isoform X2 [KO:K03456 ]
100773447 Ppp2r1a; serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform isoform X2 [KO:K03456 ]
100750924 Ppp2r2c; protein phosphatase 2, regulatory subunit B, gamma isoform X2 [KO:K04354 ]
100758873 Ppp2r2a; serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform X2 [KO:K04354 ]
100774343 serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform isoform X5 [KO:K04354 ]
100763205 Ppp2r2b; serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform X3 [KO:K04354 ]
100757400 Ppp2cb; serine/threonine-protein phosphatase 2A catalytic subunit beta isoform isoform X2 [KO:K04382 ] [EC:3.1.3.16 ]
103164195 serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform isoform X2 [KO:K04382 ] [EC:3.1.3.16 ]
118237628 Ppp2ca; serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform isoform X2 [KO:K04382 ] [EC:3.1.3.16 ]
100757208 Pias1; E3 SUMO-protein ligase PIAS1 isoform X4 [KO:K04706 ] [EC:2.3.2.-]
100769627 Grb2; growth factor receptor-bound protein 2 isoform X1 [KO:K04364 ]
100771181 Pik3r2; phosphatidylinositol 3-kinase regulatory subunit beta isoform X2 [KO:K02649 ]
100750761 Pik3r1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649 ]
100774067 phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649 ]
100689251 Pik3ca; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform isoform X1 [KO:K00922 ] [EC:2.7.1.153 ]
100769225 Pik3cd; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X2 [KO:K00922 ] [EC:2.7.1.153 ]
100689252 Pik3cb; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X2 [KO:K00922 ] [EC:2.7.1.153 ]
100760426 Bad; bcl2-associated agonist of cell death isoform X2 [KO:K02158 ]
103160601 Cdkn1a; cyclin-dependent kinase inhibitor 1 isoform X2 [KO:K06625 ]
100752928 Rb1; LOW QUALITY PROTEIN: retinoblastoma-associated protein isoform X2 [KO:K06618 ]
100758556 E2f1; LOW QUALITY PROTEIN: transcription factor E2F1 isoform X2 [KO:K17454 ]
100765017 Tnfrsf1a; tumor necrosis factor receptor superfamily member 1A isoform X2 [KO:K03158 ]
100758679 Tradd; tumor necrosis factor receptor type 1-associated DEATH domain protein [KO:K03171 ]
100773293 Faslg; tumor necrosis factor ligand superfamily member 6 isoform X1 [KO:K04389 ]
100762537 Fas; tumor necrosis factor receptor superfamily member 6 isoform X1 [KO:K04390 ]
100757136 Cflar; CASP8 and FADD-like apoptosis regulator isoform X1 [KO:K04724 ]
100758990 Ppara; peroxisome proliferator-activated receptor alpha isoform X3 [KO:K07294 ]
Compound
C05981 Phosphatidylinositol-3,4,5-trisphosphate
Reference
Authors
Hassan M, Selimovic D, El-Khattouti A, Ghozlan H, Haikel Y, Abdelkader O
Title
Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies.
Journal
Reference
Authors
Yamauchi Y, Helenius A
Title
Virus entry at a glance.
Journal
Reference
Authors
Feneant L, Levy S, Cocquerel L
Title
CD81 and hepatitis C virus (HCV) infection.
Journal
Reference
Authors
Dubuisson J, Helle F, Cocquerel L
Title
Early steps of the hepatitis C virus life cycle.
Journal
Reference
Authors
Liang TJ, Ghany MG
Title
Current and future therapies for hepatitis C virus infection.
Journal
Reference
Authors
Scheel TK, Rice CM
Title
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies.
Journal
Reference
Authors
Holmes JA, Thompson AJ
Title
Interferon-free combination therapies for the treatment of hepatitis C: current insights.
Journal
Reference
Authors
Taguchi T, Nagano-Fujii M, Akutsu M, Kadoya H, Ohgimoto S, Ishido S, Hotta H
Title
Hepatitis C virus NS5A protein interacts with 2',5'-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner.
Journal
Reference
Authors
Horner SM, Gale M Jr
Title
Intracellular innate immune cascades and interferon defenses that control hepatitis C virus.
Journal
Reference
Authors
Lemon SM
Title
Induction and evasion of innate antiviral responses by hepatitis C virus.
Journal
Reference
Authors
Horner SM, Gale M Jr
Title
Regulation of hepatic innate immunity by hepatitis C virus.
Journal
Reference
Authors
Ortega-Prieto AM, Dorner M
Title
Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection.
Journal
Reference
Authors
Yang DR, Zhu HZ
Title
Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?
Journal
Reference
Authors
Gale M Jr, Foy EM
Title
Evasion of intracellular host defence by hepatitis C virus.
Journal
Reference
Authors
Bode JG, Brenndorfer ED, Haussinger D
Title
Subversion of innate host antiviral strategies by the hepatitis C virus.
Journal
Reference
Authors
Panteva M, Korkaya H, Jameel S
Title
Hepatitis viruses and the MAPK pathway: is this a survival strategy?
Journal
Reference
Authors
Pang R, Tse E, Poon RT
Title
Molecular pathways in hepatocellular carcinoma.
Journal
Reference
Authors
Macdonald A, Harris M
Title
Hepatitis C virus NS5A: tales of a promiscuous protein.
Journal
Reference
Authors
He Y, Staschke KA, Tan SL
Title
HCV NS5A: A Multifunctional Regulator of Cellular Pathways and Virus Replication
Journal
Hepatitis C Viruses: Genomes and Molecular Biology (2006)
Reference
Authors
Lan KH, Sheu ML, Hwang SJ, Yen SH, Chen SY, Wu JC, Wang YJ, Kato N, Omata M, Chang FY, Lee SD
Title
HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis.
Journal
Reference
Authors
Majumder M, Ghosh AK, Steele R, Zhou XY, Phillips NJ, Ray R, Ray RB
Title
Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice.
Journal
Reference
Authors
Hassan M, Ghozlan H, Abdel-Kader O
Title
Activation of RB/E2F signaling pathway is required for the modulation of hepatitis C virus core protein-induced cell growth in liver and non-liver cells.
Journal
Reference
Authors
Kwun HJ, Jung EY, Ahn JY, Lee MN, Jang KL
Title
p53-dependent transcriptional repression of p21(waf1) by hepatitis C virus NS3.
Journal
Reference
Authors
Yamanaka T, Uchida M, Doi T
Title
Innate form of HCV core protein plays an important role in the localization and the function of HCV core protein.
Journal
Reference
Authors
Lim EJ, Chin R, Angus PW, Torresi J
Title
Enhanced apoptosis in post-liver transplant hepatitis C: effects of virus and immunosuppressants.
Journal
Reference
Authors
Fischer R, Baumert T, Blum HE
Title
Hepatitis C virus infection and apoptosis.
Journal
Reference
Authors
Saito K, Meyer K, Warner R, Basu A, Ray RB, Ray R
Title
Hepatitis C virus core protein inhibits tumor necrosis factor alpha-mediated apoptosis by a protective effect involving cellular FLICE inhibitory protein.
Journal
Reference
Authors
Koike K
Title
Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection.
Journal
Reference
Authors
Tanaka N, Moriya K, Kiyosawa K, Koike K, Aoyama T
Title
Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator-activated receptor alpha in transgenic mice: implications for HCV-associated hepatocarcinogenesis.
Journal
Reference
Authors
Tan A, Yeh SH, Liu CJ, Cheung C, Chen PJ
Title
Viral hepatocarcinogenesis: from infection to cancer.
Journal
Related pathway
cge04620 Toll-like receptor signaling pathway
cge04622 RIG-I-like receptor signaling pathway
KO pathway
LinkDB
All DBs